Li Xiaohua, Friedman Ari B, Roh Myoung-Sun, Jope Richard S
Department of Psychiatry and Behavioral Neurobiology, University of Alabama at Birmingham, 1720 7th Avenue South, Birmingham, AL 35294-0017, USA.
J Neurochem. 2005 Feb;92(3):701-4. doi: 10.1111/j.1471-4159.2004.02898.x.
Glycogen synthase kinase-3 (GSK3) is a crucial enzyme contributing to the regulation of neuronal structure, plasticity and survival, is implicated as a contributory factor in prevalent diseases such as Alzheimer's disease and mood disorders and is regulated by a wide range of signaling systems and pharmacological agents. Therefore, factors regulating GSK3 in vivo are currently of much interest. GSK3 is inhibited by phosphorylation of serine-9 or serine-21 in GSK3beta and GSK3alpha, respectively. This study found that accurate measurements of phospho-Ser-GSK3 in brain are confounded by a rapid post-mortem dephosphorylation, with approximately 90% dephosphorylation of both GSK3 isoforms occurring within 2 min post-mortem. Furthermore, three anesthetics, pentobarbital, halothane and chloral hydrate, each caused large in vivo increases in the serine phosphorylation of both GSK3beta and GSK3alpha in several regions of mouse brain. Thus, studies of the phosphorylation state of GSK3 in brain, and perhaps in other tissues, need to take into account post-mortem changes and the effects of anesthetics and there is a direct correlation between anesthesia and high levels of serine-phosphorylated GSK3.
糖原合酶激酶-3(GSK3)是一种关键酶,对神经元结构、可塑性和存活的调节起作用,被认为是诸如阿尔茨海默病和情绪障碍等常见疾病的一个促成因素,并且受多种信号系统和药物制剂的调节。因此,目前体内调节GSK3的因素备受关注。GSK3β和GSK3α中丝氨酸-9或丝氨酸-21的磷酸化分别抑制GSK3。本研究发现,脑内磷酸化丝氨酸-GSK3的准确测量受到死后快速去磷酸化的干扰,两种GSK3亚型在死后2分钟内约90%发生去磷酸化。此外,三种麻醉剂,戊巴比妥、氟烷和水合氯醛,各自在小鼠脑的几个区域均引起体内GSK3β和GSK3α丝氨酸磷酸化大幅增加。因此,对脑内以及可能在其他组织中GSK3磷酸化状态的研究需要考虑死后变化以及麻醉剂的影响,并且麻醉与高水平丝氨酸磷酸化GSK3之间存在直接关联。